Vitexin induces apoptosis through mitochondrial pathway and PI3K/Akt/mTOR signaling in human non-small cell lung cancer A549 cells
Abstract Background: Currently, the prognosis of patients with non-small cell lung cancer (NSCLC) remains dismal; hence, it is critical to identify effective anti-NSCLC agents with limited side effects. This study aimed to evaluate the therapeutic potential of flavonoid compound vitexin in human NS...
Guardado en:
Autores principales: | , , , |
---|---|
Lenguaje: | English |
Publicado: |
Sociedad de Biología de Chile
2019
|
Materias: | |
Acceso en línea: | http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0716-97602019000100206 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:scielo:S0716-97602019000100206 |
---|---|
record_format |
dspace |
spelling |
oai:scielo:S0716-976020190001002062019-10-10Vitexin induces apoptosis through mitochondrial pathway and PI3K/Akt/mTOR signaling in human non-small cell lung cancer A549 cellsLiu,XiaoliJiang,QingfengLiu,HuaiminLuo,Suxia Non-small cell lung cancer Vitexin Mitochondrial dysfunction PI3K/Akt/mTOR signaling Abstract Background: Currently, the prognosis of patients with non-small cell lung cancer (NSCLC) remains dismal; hence, it is critical to identify effective anti-NSCLC agents with limited side effects. This study aimed to evaluate the therapeutic potential of flavonoid compound vitexin in human NSCLC cells and the underlying mechanisms. Results: The experimental results indicated that vitexin reduced the viability of A549 cells in a dose-dependent manner with nearly no toxicity against normal human bronchial epithelial 16HBE cells. Vitexin also dose-dependently increased A549 cell apoptosis, accompanied by the decreased Bcl-2/Bax ratio and the increased expression of cleaved caspase-3. Moreover, the in vivo anticancer activity of vitexin was further determined in nude mice bearing A549 cells. In addition, vitexin induced the release of cytochrome c from the mitochondria to the cytosol and the loss of mitochondrial membrane potential. Vitexin also significantly reduced the levels of p-PI3K, p-Akt and p-mTOR, and the pro-apoptotic effect of vitexin on A549 cells was partly blocked by SC79, an Akt activator. Conclusions: Accordingly, we believed that vitexin could be used as a potential therapeutic agent for the treatment of NSCLC in the future.info:eu-repo/semantics/openAccessSociedad de Biología de ChileBiological Research v.52 20192019-01-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0716-97602019000100206en10.1186/s40659-019-0214-y |
institution |
Scielo Chile |
collection |
Scielo Chile |
language |
English |
topic |
Non-small cell lung cancer Vitexin Mitochondrial dysfunction PI3K/Akt/mTOR signaling |
spellingShingle |
Non-small cell lung cancer Vitexin Mitochondrial dysfunction PI3K/Akt/mTOR signaling Liu,Xiaoli Jiang,Qingfeng Liu,Huaimin Luo,Suxia Vitexin induces apoptosis through mitochondrial pathway and PI3K/Akt/mTOR signaling in human non-small cell lung cancer A549 cells |
description |
Abstract Background: Currently, the prognosis of patients with non-small cell lung cancer (NSCLC) remains dismal; hence, it is critical to identify effective anti-NSCLC agents with limited side effects. This study aimed to evaluate the therapeutic potential of flavonoid compound vitexin in human NSCLC cells and the underlying mechanisms. Results: The experimental results indicated that vitexin reduced the viability of A549 cells in a dose-dependent manner with nearly no toxicity against normal human bronchial epithelial 16HBE cells. Vitexin also dose-dependently increased A549 cell apoptosis, accompanied by the decreased Bcl-2/Bax ratio and the increased expression of cleaved caspase-3. Moreover, the in vivo anticancer activity of vitexin was further determined in nude mice bearing A549 cells. In addition, vitexin induced the release of cytochrome c from the mitochondria to the cytosol and the loss of mitochondrial membrane potential. Vitexin also significantly reduced the levels of p-PI3K, p-Akt and p-mTOR, and the pro-apoptotic effect of vitexin on A549 cells was partly blocked by SC79, an Akt activator. Conclusions: Accordingly, we believed that vitexin could be used as a potential therapeutic agent for the treatment of NSCLC in the future. |
author |
Liu,Xiaoli Jiang,Qingfeng Liu,Huaimin Luo,Suxia |
author_facet |
Liu,Xiaoli Jiang,Qingfeng Liu,Huaimin Luo,Suxia |
author_sort |
Liu,Xiaoli |
title |
Vitexin induces apoptosis through mitochondrial pathway and PI3K/Akt/mTOR signaling in human non-small cell lung cancer A549 cells |
title_short |
Vitexin induces apoptosis through mitochondrial pathway and PI3K/Akt/mTOR signaling in human non-small cell lung cancer A549 cells |
title_full |
Vitexin induces apoptosis through mitochondrial pathway and PI3K/Akt/mTOR signaling in human non-small cell lung cancer A549 cells |
title_fullStr |
Vitexin induces apoptosis through mitochondrial pathway and PI3K/Akt/mTOR signaling in human non-small cell lung cancer A549 cells |
title_full_unstemmed |
Vitexin induces apoptosis through mitochondrial pathway and PI3K/Akt/mTOR signaling in human non-small cell lung cancer A549 cells |
title_sort |
vitexin induces apoptosis through mitochondrial pathway and pi3k/akt/mtor signaling in human non-small cell lung cancer a549 cells |
publisher |
Sociedad de Biología de Chile |
publishDate |
2019 |
url |
http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0716-97602019000100206 |
work_keys_str_mv |
AT liuxiaoli vitexininducesapoptosisthroughmitochondrialpathwayandpi3kaktmtorsignalinginhumannonsmallcelllungcancera549cells AT jiangqingfeng vitexininducesapoptosisthroughmitochondrialpathwayandpi3kaktmtorsignalinginhumannonsmallcelllungcancera549cells AT liuhuaimin vitexininducesapoptosisthroughmitochondrialpathwayandpi3kaktmtorsignalinginhumannonsmallcelllungcancera549cells AT luosuxia vitexininducesapoptosisthroughmitochondrialpathwayandpi3kaktmtorsignalinginhumannonsmallcelllungcancera549cells |
_version_ |
1718441585044094976 |